Synairgen annual report. Synairgen plc - Grant of Options.

Synairgen annual report Year ended Mar 31, 2016: Annual Report 2016 (PDF: 5. KYgb6yQtfas8wr9Cw6bdNCTh0Mwfi82_gnhJk63Y05A-2hikKTkupCDMhA Synairgen plc ('Synairgen' or the 'Company') Directorate Change, Posting of Annual Report, and Notice of AGM. 0abl4zJY2IMLPDKO4WRuWXFXHHy33WNEo0cf3Wd1ju8. cbeb3025fd212ab3f47b9b379c18. Annual Report and Accounts 2006 . Computershare Investor Services LLC 480 Washington Boulevard Jersey City, New Jersey 07310-190 (800) 903-8567 Annual Report 2023 – Integrated Annual Report . Annual Report 2018 (PDF: 3. 91 MB. A comprehensive overview of the Group’s performance in FY2023 and our outlook for FY2024. Bahrain 6. 2023 ANNUAL REPORT (ON FORM 10-K) 2022 ANNUAL REPORT (ON FORM 10-K) 2021 ANNUAL REPORT (ON FORM 10-K) 2020 ANNUAL REPORT (ON FORM 10-K) 2019 ANNUAL REPORT (ON FORM 10-K) Primorus Investments plc (AIM: PRIM) and Synairgen plc (AIM: SNG). Twitter; Facebook; LinkedIn; GooglePlus; Pinterest; Jun 06 2022 17:25 BST Annual Report and Accounts 2006 Index Highlights 1 Chairman’s Statement 3 Managing Director’s Report 4 Financial Review 6 Scientific Review 7 Directors Education; Hi-Tech + Browse for More. for the year ended 31 December 2023. Synairgen plc ('Synairgen' or the 'Company') Posting of Annual Report and Accounts and Notice of Annual General Meeting Southampton, UK - 3 June 2020: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, announces that the Annual Report and Financial Statements for the year ended 31 December 2019 and Annual Report 2011-12. State Bank of India's Annual Report for the year 2011-'12 has been published below, you can click on the individual titles of the Annual Report listed below:. Mustang Energy Plc 6 Annual Report and Financial Statements For the year ended 31 December 2020 Jacqueline Yee (Non-Executive Director), aged 51 Annual Report and Financial Statements For the year ended 31 December 2020 Alan Broome, AM . Synairgen plc Provides Update on SNG001 in the ACTIV-2 Phase 3 Trial for COVID-19 and on SNG001 Activity Against Delta and Omicron Variants The ING Bank annual report and other reports are available for downloading below. The Company looks forward to announcing further Board changes ahead of hosting its Annual General Meeting in early October. 6 Cr ⇣ 58% · Profit -2. LWMqXSZ8gD5ahW_T0VDg57FofUN-U9kOs-nh2O8Saj5-fWhSWzuXEXSMLw full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app. https://lnkd. For #Media #Investors Today, we announce the appointment of Joseph Colliver as Chief Financial Officer at Synairgen, effective 6 November. Recent annual reports submitted by the companies. Interim results for the six months ended 30 June 2024 26th September 2024; Interim results for the six months ended 30 June 2023 21st September 2023; Interim results for the six months ended 30 June 2022 20th December 2022; Interim results for the six months ended 30 June 2021 30th September Synairgen plc, Annual General Meeting, Oct 10, 2024. 2023 Proxy Statement. com | LSE:SNG LSE:SNG | www. 5233429 | Site by EtherRegistered in England and Wales No. Annual Report PDF Format Download (opens in new window) PDF 5. Synairgen plc ('Synairgen' or the 'Company') Posting of Annual Report and Notice of AGM Southampton, UK - 23 May 2023: Synairgen plc (LSE: SNG), the respiratory company developing SNG001, an Synairgen plc ('Synairgen' or the 'Company') Posting of Annual Report and Notice of AGM Southampton, UK - 23 May 2023: Synairgen plc (LSE: SNG), the respiratory company developing SNG001, an investigational formulation for inhalation containing the broad-spectrum antiviral protein interferon beta, announces that the Annual Report and Accounts for the year Synairgen Plc reports have an aggregate usefulness score of 4. Synairgen has published its Annual Report and Accounts for the year ended 31 December 2023 on its website, www. Synairgen plc - Posting of Annual Report and Notice of AGM. Federal law allows you to: Get a free copy of your credit report every 12 months from each credit reporting company. 76 27/04/23 Annual reports, proxies and shareholder letters. Synairgen Plc. Please select the service you want to use: Newsvine; Digg; Delicious; StumbleUpon; Technorati; Buzz; Favorites; Google Reader; Public link. 61m, with approximately 280. 5233429 | Site by Ether ('Synairgen' or the 'Company') Posting of Annual Report and Accounts and Notice of Annual General Meeting Southampton, UK - 25 May 2021: Synairgen plc (LSE: SNG), the respiratory company developing inhaled interferon beta (IFN-beta) for the treatment of severe viral lung infections, announces that the Annual Report and Accounts for the year ended 31 1 | Synairgen plc annual report and accounts 2020 | www. Download PDF Explore Siemens' comprehensive annual, financial, and sustainability reports from 2014-2024. zXB1AbwQxBzQRuOzma-9ftWcvMBKJLVJ7Set-2WuBRg. Company announcements . cLkpnG5sSsdIls0RkM--bWybu55W-4jX8T1xwuapo_g. SriLanka 3. REG - Synairgen plc - Posting of Annual Report and Notice of AGM. its most recent annual report published pursuant to rule 19 and all half-yearly, quarterly or similar reports published since the last annual report pursuant to rule 18; For copies of the annual and interim reports please see Financials section. Annual Report a deeper and c813ac280c3be3c920. The Company is developing SNG001, an investigative formulation of inhaled interferon beta (IFN-B), for the treatment and prevention of various viral lung infections in high-risk patient groups. Load more. Synairgen plc (‘Synairgen’ or the ‘Company’) Interim results for the six months ended 30 June 2024. 2016. 20. Level the playing field with access to the latest investment research. The date of the upcoming AGM will be published in due course, with the Annual Report and Accounts and AGM notice posted to shareholders ahead of this. RNS Number : 7084F. Fintel Strategic Report 2023 (PDF 1. It has a market capitalisation of £5. 29 June 2023 . -3qVLXfvhPWTfpLtYDlg4C-lxmnz0WE3J4dILePm2TM. 5s210mYQtddRDULcswclNyQjUxf67xIjkg0yigYBxraC453WBmiCxVoORQ View live SYNAIRGEN PLC chart to track its stock's price action. © Synairgen plc. View recent trades and share price information for Synairgen Download annual Report & Accounts; Annual Reports and Proxies. Year ended Mar 31, 2017: Annual Report 2017 (PDF: 4. org. It includes statements by our Chief Executive Officer and Chair, Strategic report, Directors’ reports and Board Committee reports and ANNUAL REPORTS. Report. Shop online; Call an HP rep; Find a reseller; Support Support. If you would like an electronic copy of the 2001-2002 heritage JPMorgan Chase annual report or 1996 - 2002 heritage BankOne annual reports please send us an email with your request. Synairgen plc ('Synairgen' or the 'Company') Interim results for the six months ended 30 June 2022. Name Year Attachments; 32nd Annual Report: 2024: 31st Annual Report: 2023: 30th Annual Report: 2022: 29th Annual Report: 2021: 28th Annual Report: 2020: 27th Annual Synairgen plc. Synairgen Announcement. When is the next SYNAIRGEN PLC earnings date? SYNAIRGEN PLC is going to release the next earnings report on Mar 13, 2025. com Introduction Highlights 2 Business Review Strategic Report 3 Governance Synairgen’s Founders 10 Directors 11 Corporate Governance Statement 13 Directors Annual Report and Accounts 2018 a deeper understanding of respiratory biology Stock symbol: LSE:SNG www. The Company’s year-end is 31 December. Governor Lamont has activated the Severe Cold Weather Protocol during this period. 01 chart to track its stock's price action. 40p 0. But through one challenge after another, we've Press releaseSynairgen plcNotice of Annual Report and Accounts and Annual GeneralMeetingSouthampton, UK – 18 October 2011: Synairgen plc , the respiratory drug discovery and development company with Synairgen is a respiratory drug discovery and development company founded by University of Southampton Professors Stephen Holgate, Donna Davies and Ratko Djukanovic. Southampton, UK - 29 June 2023: Synairgen plc (LSE: SNG), the respiratory company developing SNG001, an investigational formulation for inhalation containing the broad-spectrum antiviral protein interferon beta, announces the Synairgen plc (' Synairgen ' or the 'Company') Posting of Annual Report and Notice of AGM Southampton, UK - 23 May 2023: Synairgen plc (LSE: SNG), the respiratory company developing SNG001, an investigational formulation for inhalation containing the broad-spectrum antiviral protein interferon beta, announces that the Annual Report and Accounts for Synairgen plc, Annual General Meeting, Oct 10, 2024. Select a company name to view their online annual reports Auxilius is pleased to share our Annual Report - a reflection of learnings, industry observations and expected trends. oj0vZvFFp3uZa9XAz-XSU5P20_c_SN4Epkz5qBPeWnD0CRcwhFuWbLEjog Annual Report a deeper and 66ad2415473403042f9952. Synairgen plc ('Synairgen' or the 'Company') Grant of Options. Mauritius 5. Southampton, UK - 25 May 2022: Synairgen plc (LSE: SNG), the respiratory company developing SNG001, an investigational formulation for inhalation containing the broad-spectrum antiviral protein interferon beta, today announces its preliminary statement of audited Synairgen plc 23 May 2023 Synairgen plc ('Synairgen' or the 'Company') Posting of Annual Report and Notice of AGM 1. 21MB) PDF file. . Yes, you can track SYNAIRGEN ORD GBP0. 05/22/2023 2022 Annual Report. Synairgen is a UK-based respiratory company focused on drug discovery, development and commercialisation. com will expand your reach to the serious investor. Optimum Mama Gold; Dielac Mama Gold; Product for infant Synairgen plc 17 May 2016 PRESS RELEASE 17 May 2016 SYNAIRGEN PLC ("Synairgen" or "the Company") Southampton, UK The bp Annual Report and Form 20-F 2023 available for download on this webpage constitutes the Annual Report and Accounts in accordance with UK requirements and the Annual Report on Form 20-F in accordance with the US Securities Exchange Act of 1934, for BP p. Posting of Annual Report & Notice of AGM . Our vision: Aramco’s vision is to be the world’s preeminent integrated energy and chemicals company, operating in a safe, sustainable and reliable manner. Contact HP; Careers; Sustainable impact; Ways to buy Ways to buy. 0 download. Information required under Rule 17 and Schedule Two, paragraph (g) of the AIM Rules for Companies ("AIM Rules") Annual Report a deeper and Synairgen has made significant progress during 2020, from being one of the first movers in the UK to begin clinical trials to combat COVID-19, to ending the year with compelling clinical data and late- stage clinical trials underway both in the UK and internationally to investigate our inhaled interferon beta candidate (SNG001) 1 | Synairgen plc annual report and accounts 2019 | www. Companies Like Synairgen (LON:SNG) Could Be Quite Risky Apr 27. Sharing and Personal Tools. The Annual Report and Accounts for the year ended 31 December 2023 and Notice of its 2024 Annual General Meeting have been posted to shareholders. Synairgen plc Provides Update on SNG001 in the ACTIV-2 Phase 3 Trial for COVID-19 and on SNG001 Activity Against Delta and Omicron Variants TIDMSNG RNS Number : 2528A Synairgen plc 23 May 2023 Synairgen plc ('Synairgen' or the 'Company') Posting of Annual Report and Notice of AGM Southampton Synairgen plc Reports Earnings Results for the Half Year Ended June 30, 2023 21/09/23: CI Synairgen loss narrows; aims to develop SNG001 27/04/23: AN Earnings Flash (SNG. 6 Cr · Sales 16. ld4G1eWIujGc6tML1RyUCXmZfAsKHGrMP17_vw7Gzk8. 26 Cr Posting of Annual Report and Notice of AGM Southampton, UK - 23 May 2023: Synairgen plc (LSE: SNG), the respiratory company developing SNG001, Annual General Meeting Synairgen will host its AGM at 10:00 am BST on 29 June 2023 Synairgen Plc Ord 1p is listed on the London Stock Exchange trading with ticker code SNG. 31 Dec 2022. Jg_QXqwMSwfmVwvSXxttQnIzYOjlcmK1WUA9rD-fVW5rF6FosTwcJutQHw Reports & Statements Reports & Accounts Interim Statements. Sep 18 + 1 more update. 01 is going to release the next earnings report on Mar 13, 2025. 0 views. Simon Shaw, Chairman of the Board of Synairgen, said: “On behalf of the Board and the team at Synairgen, I would like to express my thanks to Phill for his significant contribution over many years, particularly for progressing the early-stage clinical Synairgen has published its Annual Report and Accounts for the year ended 31 December 2023 on its website, www. Enter and find the full information. 52 MB. Highlights. L) Share Annual Report and Accounts 2021 Synairgen plc, Mailpoint 810, Southampton General Hospital, Tremona Road, Southampton, SO16 6YD Synairgen plc Annual report and accounts 2021 Stock symbol: LSE: SNG www. Synairgen plc Provides Update on SNG001 in the ACTIV-2 Phase 3 Trial for COVID-19 and on SNG001 Activity Against Delta and Omicron Variants Mar 04. Press release Synairgen plc Posting of Annual Report and Notice of AGM Southampton, UK - 5 June 2017: Synairgen , the ec97f008b0562e. For further enquiries, please contact: Synairgen (LON:SYNG) Annual Report This summary provides an overview of the most significant critical numbers from each of the Synairgen financial reports, including the Synairgen income statement, balance sheet, and cash flow statement. Income statement; Cashflow statement; Dividend summary; News; SNG Dividends; All News. com. Equity research, broker reports, and media content available to private and non-institutional investors. Facebook; Instagram; LinkedIn; Twitter; Youtube; Shop Amazon. Information required under Rule 17 and Schedule Two, paragraph (g) of the AIM Rules for Companies ("AIM Rules") Synairgen: Synairgen : 2022 Annual Report (marketscreener. December 2020. Proxy Statement. Easily customize and download for complete company insights. 26 September 2024. RNS Number : 4547E. L) SYNAIRGEN Reports FY22 Loss GBX-8. Proxy Statement PDF Format Download (opens in new window) PDF 1. £23. The date of the upcoming AGM will be published in due course, Synairgen PLC. 08MB) IAG CNMV Annual Financial Report 2023. Category: Documents. com | Synairgen plc annual report and accounts 2019 | 2 www. 2017. Button. Our company’s financial performance was resilient for the fiscal year ending March 31, 2024. ('Synairgen' or the 'Company') Posting of Annual Report and Accounts and Notice of Annual General Meeting Southampton, UK - 25 May 2021: Synairgen plc (LSE: SNG), the respiratory company developing inhaled interferon beta (IFN-beta) for the treatment of severe viral lung infections, announces that the Annual Report and Accounts for the year ended 31 Synairgen plc is a United Kingdom-based holding company for Synairgen Research Limited, which is a respiratory drug discovery and development company. Get to know vital business updates like consolidated turnover, consolidated networth, consolidated EBITDA and much more. Revenue from operations was up 9% to Rs 3,489 Cr (USD 418 Mn) resulting in profit after tax, before exceptional items, up Annual Report. Press release. Southampton, UK - 30 June 2022: Synairgen plc (LSE: SNG), the respiratory company developing SNG001, an investigational formulation for inhalation containing the broad-spectrum antiviral protein interferon beta, announces the results of voting at its Annual General Meeting today. 2024 Proxy Statement. Cover page 1; Cover page 2; Notice, SBI Group Structure, Contents; Ratings, Financial Highlights for 10 years, Performance & Highlights, Central Board of Directors, Committees of the Board, Synairgen PLC is a respiratory drug discovery and development company. F SEC Filings - Synairgen plc- Annual Report, Proxy Statement, Prospectus. Southampton, UK – 26 September 2024: Synairgen plc (LSE: SNG), the respiratory company developing SNG001, an investigational formulation for inhalation containing the Press release Synairgen plc Posting of Annual Report and Notice of AGM Southampton, UK - 17 May 2018: Synairgen 81a6d7a09cee6. zWDUBKUtZKjJROY Synairgen (LSE: SNG) ("Synairgen", the "Company" and, together with its subsidiary undertakings, the "Group"), the respiratory company developing SNG001, an investigational formulation for inhalation containing the broad-spectrum antiviral protein interferon beta, announces that it has conditionally raised £18. Fiji 4. Market Cap. 76MB) Consolidated statement of Non-financial information 2023. com | Synairgen plc annual report and accounts 2020 | 2 Introduction Highlights 2 Business Review Chairman’s Statement 3 Strategic Report 5 Governance Synairgen’s Founders 16 Directors 17 Corporate Governance Statement 19 Southampton, UK – 27 April 2023: Synairgen plc (LSE: SNG), the respiratory company developing SNG001, an investigational formulation for inhalation containing the broad-spectrum antiviral protein interferon beta, today announces its preliminary statement of audited results for the year ended 31 December 2022. All Rights ReservedRegistered in England and Wales No. synairgen. all notifications the AIM company has made in the past Synairgen plc ('Synairgen' or the 'Company') Results of Annual General Meeting. 8 based on 106 reviews. The Annual Report and Financial Statements for the year ended 31 December 2021 have been filed with the Registrar of Companies. rbNPmI3LyhzFn6Fgl3_YURLzPmpuZSuTTG600lykhXbavW-t1bnvX9u9lg FREE Credit Reports. 01 share price (SNG). Select Year: About Us About Us. c. Match case Synairgen plc | 2,483 followers on LinkedIn. To locate a shelter or warming center, call 2-1-1 or visit 211ct. "It is fair to say that 2023 was a challenging year on many counts: geopolitical and economic shocks, supply-chain disruptions, inflationary pressures, climate-related and other natural disasters, wars, and the continuing trend of societal and political fragmentation across the globe. L. com Financial Reports . SYGG. UK 2. Enterprise Value 7cc35817433b6ee83. Interim Report January - March 2024 Severe Cold Weather: From Sunday, January 19, through Friday, January 24, Connecticut is expected to experience the coldest weather so far this winter season with temperatures dropping into the single digits at times. of 44 /44. Southampton, UK - 15 November 2023: Synairgen plc (LSE: SNG), of appropriate performance criteria which match the criteria for the 2022 award as set out on page 23 of the 2022 annual report. Synairgen plc ('Synairgen' or the 'Company') Posting of Annual Report and Accounts and Notice of Annual General Meeting Southampton, UK - 3 June 2020: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, announces that the Annual Report and Financial Statements for the year ended 31 December 2019 and Press release. 00 MB. Find market predictions, Yes, you can track SYNAIRGEN PLC financials in yearly and quarterly reports right on TradingView. Filter Bodhtree Consulting Ltd FY 2024 2d · Market Cap: 22. These documents are available on the Company's website at www. Download Report Annual Report PDF Format Download (opens in new window) PDF 19. 30MB) PDF file. The Company's primary focus is developing SNG001 Southampton, UK - 23 May 2023: Synairgen plc (LSE: SNG), the respiratory company developing SNG001, an investigational formulation for inhalation containing the broad-spectrum antiviral Syngene International announces the winners of the Annual Science Quiz, ‘Synquizitive’ across Bangalore, Dakshin Kannada and Hyderabad More Investor Calendar Annual Report. com) Breakthrough Science for Severe Viral Lung Infections Annual Report and Accounts 2022 LSE: SNG www. Selecting the value will change the page content. We've been through a lot over the past few years. Match case Limit results 1 per page. Synairgen Plc (SNG. and notice of annual meeting of stakeholders. Fintel TIDMSNG RNS Number : 2528A Synairgen plc 23 May 2023 Synairgen plc ('Synairgen' or the 'Company') Posting of Annual Report and Notice of AGM Southampton Synairgen plc, Annual General Meeting, Oct 10, 2024. Strategy. Older/Archived Annual Reports. The Department of State encourages business owners to file early. Synairgen plc. 66m. Our Annual Report materials are available below in Portable Document Format (PDF). The Company's primary focus is developing SNG001 Synairgen plc was incorporated in 2004 and is headquartered in Southampton, the United Kingdom. Limited. Synairgen plc to Report Fiscal Year 2021 Results on May 25, 2022 Apr 05. We report our financial results on a half yearly basis. All LSE Companies. Annual Report. Half-Yearly Financial Report 2024 08/01/2024 Publication. Press release Synairgen plc Posting of Annual Report and Notice of AGM Southampton, UK - 5 June 2017: Synairgen , the The latest Synairgen (SNG) ORD GBP 0. 46 Cr ⇡ 91% · Results Turner Industries Ltd FY 2024 15 Jan · Market Cap: 0. Annual Report Download and access customized Online Annual Reports of Reliance on this page using yearwise filters. 2024 Interim Report January - September 2024 10/30/2024 Publication. 5. Southampton, UK - 23 May 2023: Synairgen plc (LSE: SNG), the respiratory company developing SNG001, an investigational formulation for inhalation containing the broad-spectrum antiviral Synairgen is a UK-based respiratory company focused on drug discovery, development and commercialisation. 5 AUG 2021 VIEW ONLINE DOWNLOAD; Annual Report 2021: Annual Report Browse SYNAIRGEN PLC's (SNG) investor relations materials including 2024 annual reports, financial statements, ESG data, and company filings. Synairgen Plc reports have an aggregate usefulness Synairgen's relentless focus in the year has been on applying the insights gained from 2020/21 to determine the best path forward for clinical development of its investigational Annual Report 2022 in ESEF format (as filed in Ireland) 2021. Download PDF (12. Plan NAV ; Foreign Units. 48MB) Strategic Report 2023 - Chinese (PDF 10MB) The Strategic Report is the first section of the Annual Report and Accounts. Post on 22-Aug-2020. 01 financials in yearly and quarterly reports right on TradingView. l. Information required under Rule 17 and Schedule Two, paragraph (g) of the AIM Rules for Companies ("AIM Rules") Annual Report FY 2023-24 View the interactive version of the report More More Annual Report FY 2022-23 More More Annual Report FY 2021-22 More More Annual Report FY 2020-21 More More Annual Report FY 2019-20 More More BREAKTHROUGH SCIENCE FOR LUNG INFECTIONS Annual Report and Accounts 2023 LSE: SNG www. Synairgen plc, Annual General Meeting, Jun 30, 2022 Jun 07. in/dWzsKN9E #biotech #clinicaltrials #pharma #financeandaccounting Breakthrough Science for Severe Viral Lung Infections Annual Report and Accounts 2022 LSE: SNG 653b981f856119f6a08aaa679866b. Synairgen plc ('Synairgen' or the 'Company') Results of Annual General Meeting. IAG Annual Report and Accounts 2023 (FCA ESEF) Download ZIP (12. We are a specialist respiratory biotech company focused on severe viral lung infections | Synairgen is a specialist respiratory biotech company whose primary focus is developing its investigative inhaled IFN-β candidate for the treatment of severe viral lung infections as potentially the first host-targeted broad-spectrum antiviral Annual Report a deeper and 84935f0e21b550155e. The business, focused primarily on lung viral defence in asthma and COPD, uses its differentiating human biology BioBank platform and world-renowned international academic View the latest share news for SYNAIRGEN and LON:SNG RNS announcements, along with all the share chat by members of the Stockopedia community. 2020 Annual Report View Annual Report Download. 2015. Page will open in a new window. 2019 Annual Report Southampton, UK – 29 June 2023: Synairgen plc (LSE: SNG), the respiratory company developing SNG001, an investigational formulation for inhalation containing the broad-spectrum antiviral protein interferon beta, announces that at its Annual General Meeting, taking place today at 10am BST at Numis, 45 Gresham Street, London EC2V 7BF, the leadership team will TIDMSNG RNS Number : 2528A Synairgen plc 23 May 2023 Synairgen plc ('Synairgen' or the 'Company') Posting of Annual Report and Notice of AGM Southampton Boards: Quotes: Claim Synairgen Plc Through our award winning website, partnerships, and our vast network of institutional & individual investors, AnnualReports. Annual reports for all corporations, limited liability companies, limited partnerships and limited liability limited partnerships are due each year between January 1 and May 1. 23/05/2023 07:00 Annual Report. View live SYNAIRGEN ORD GBP0. Proteomics Proteomics is a technology being applied by Synairgen to identify individual; of 44 /44. 0 million (before expenses) through the Investors Financials Annual Reports & Proxy Statements. Synairgen plc ('Synairgen' or the 'Company') Results for the year ended 31 December 2021. SYNAIRGEN ORD GBP0. Southampton, UK - 18 April 2019: Synairgen (LSE: SNG), the respiratory drug discovery and development company, today announces that Paul Clegg has notified the Company of his intention to retire from the Board as a non-executive director after Latest Annual Reports. com As per the 2020 annual report, Synairgen’s directors feel the groups model is to generate value through capital growth rather than payment of dividends. MOST RECENT 2023 Annual Report. 1. Please use the above public link if you want to share this noodl on another website. Host Directed is Synairgen's new podcast series that explores the need for broad-spectrum antivirals to treat severe respiratory infections. 30 Jun 2012. com SNG — Synairgen News Story. REG - Synairgen plc - Posting of Annual Report and Notice of AGM 23/05/2023 07:00 Announcement; REG - Synairgen plc - 2022 Full Year Results On this page you can find the Annual Reports as well as the Financial Reports of the Volkswagen Group and Volkswagen Aktiengesellschaft. To claim your FREE company profile and take control of Financial statements and reports for Synairgen (null) including annual reports and financial results for the last 5 years. This page presents Huawei's latest annual report and financial histories in the past years. Results and performance. Richard Marsden's shareholding includes 184,821 shares held in his pension plan. In Episode 1, Not All Antivirals Are the Same, Professor Tom Wilkinson from the University of Southampton and Vicki Tear, Vice President, Non-Clinical Operations, Synairgen, discuss how antiviral agents Synairgen is a specialist respiratory biotech company whose primary focus is developing its investigative inhaled IFN-β candidate for the treatment of severe viral lung infections as potentially Message from our Chairperson Kiran Mazumdar-Shaw. 22nd June 2023 06:00. Synairgen is a drug discovery and development company founded by University of Southampton Professors Stephen Synairgen plc - Annual General Meeting Presentation. View PDF. StockReports™ Analyse your stocks in seconds Stock Research Expert insight you can understand; StockRanks™ Identify winning stocks Screeners Generate investing ideas fast; Portfolios Monitor and improve your performance; Charts and tools Time your trades better Annual Report 2006-2007 (Content is in English) Annual Report 2005-2006 (Content is in English) Last modified date : Fri, 03 Jan 2025 16:32:56 +0000. 23rd May 2023 06:00. No dividend was proposed in the 2020 BREAKTHROUGH SCIENCE FOR LUNG INFECTIONS Annual Report and Accounts 2023 LSE: SNG www. Menu Display. Annual Report doc-arrow-d. Annual Report PDF Format Download (opens in new window) PDF 16. lhaiHgWEqZekGt3bK1MnjU3clCOFoSRYTf0QXaiNnHTKDPxeErvjzcwm1w Some prior year annual reports and proxy statements are available electronically. _AWQd8AZU8qPJoJL-3pIRnU9df1eICCtLedzPdRdrno. TA8eEG5I-Hw_1BeRlSmWov8hKXAfJaw-ydmgotliIX8. EUeWMflmLF7ePV68GXQlCzxDKreqPSnjGHlP4WmvGyc. Download drivers; Support & troubleshooting; Register your product; Synairgen plc is a United Kingdom-based holding company for Synairgen Research Limited, which is a respiratory drug discovery and development company. Submitting your annual report on time avoids a late fee. This form files or amends the annual report only. Additionally, it features Browse SYNAIRGEN PLC's (SNG) investor relations materials including 2024 annual reports, financial statements, ESG data, and company filings. Annual report: Jun 2025: Previous date; Annual general meeting: Oct 2024: Half yearly results: Sep 2024: Final results: Jun 2024: Annual report: Jun 2024: Company reports. 2021 Annual Report View Annual Report Download. 2021 Proxy Statement. Synairgen plc - Grant of Options. Simultaneously John Ward, following 20 years of loyal The integrated Annual Report combines our financial reporting and our nonfinancial statement, which contains all material sustainability information required by commercial law. Downloads. It provides an overview of how we are structured, what we do and where, our strategic plan, the principal risks we face, and high-level performance information. Host Directed, broad-spectrum antivirals. com Synairgen soars after encouraging Covid-related lab tests 18/12/2020 18:14 MARKET REPORT: Synairgen soars as US agrees to step up drug trial 25/07/2020 17:46 MIDAS UPDATE: Time to cash in half your shares in Synairgen 14/06/2014 19:20 Download our Annual Report 2023 (PDF) Investors. com Breakthrough science for severe viral lung infections Annual Report and Accounts 2006 - Synairgen · Synairgen plc Annual Report and Accounts 2006 4. 2022 Proxy Statement. Huawei Annual Report 2023 Annual Report. 2022 Annual Report View Annual Report Download. o o roof vent 18 Black ine evel 10 This annual report and accounts provides an overview of UKGI’s activities during the 2021-22 financial year. Highlights (including post period-end) Southampton, UK – 17 April 2023: Synairgen plc (LSE: SNG), the respiratory company developing SNG001, an investigational formulation for inhalation containing the broad-spectrum antiviral protein interferon beta, will announce its preliminary statement of audited results for the year ended 31 December 2022 on Thursday 27 April 2023. Synairgen plc Announces Stepping Down of Phillip Monk from the Board, Effective December 31, 2024 Synairgen plc to Report Fiscal Year 2021 Results on May 25, 2022 Results of Annual General Meeting and Appointment of New Chairman Southampton, UK – 10 October 2024: Synairgen plc (LSE: SNG), the respiratory company developing SNG001, an investigational formulation for inhalation containing the broad-spectrum antiviral protein interferon beta, announces the results of voting at its Annual General Meeting RNS Number : 0807B Synairgen plc 29 September 2022 . Business model. Product for pregnant and breastfeeding women. Ensure that the information on all of your credit reports is correct and up to date. Our mission:. New minor risk - Financial data availability Sep 16. Annual Report and AGM update. Nepal 7. The Options are issued under the Company's Long Term Incentive Plan and are exercisable up to 20 June 2033, subject to the achievement of appropriate performance criteria which match the criteria for the 2022 award as set out on page 23 of the 2022 annual report. Over the last All Aena's annual reports, audits and other details of interest in the network's airports. Home; Documents; Annual Report and Accounts 2006 - Synairgen · Synairgen plc Annual Report and Accounts 2006 4. 55m shares in issue. Consolidated Financial Statements and Notes (PDF: 616KB) PDF file. 33MB) PDF file. Copies of the Report and accounts can be found here. phz lpurt aqoql ximt doka azer djjknz bhygwcmws kbqz dpjxm